Newsletter | August 24, 2026

08.24.26 -- Where Drug Delivery Is Headed Next: Inhalation, Nanoparticles & Beyond

SPONSOR

Redefining Prefillable Syringe Systems

A prefillable syringe platform streamlines early drug product development by providing an integrated, system-level approach to accelerate clinical fill. Built around a single verification package, compatibility assessments, aligned shipping formats, and system-level testing, it reduces development complexity and unnecessary testing. A structured documentation pathway guides teams from feasibility through regulatory submission, simplifying system selection, supporting consistent performance, and helping manufacturers bring safe, effective therapies to patients more efficiently.

FEATURED EDITORIAL

Expanding Targets For Inhalation Delivery

In this article, Chief Editor Tom von Gunden considers the expanding range of addressable targets for inhalation drug and biologics delivery. He reports on innovations in oral and nasal inhalation technology that enhance approaches to traditional respiratory indications, as well enable delivery of inhaled therapies to systemic targets beyond the nose and lungs.

Designing Nanoparticles: Why Size Comes First

Successful nanoparticle programs choose size intentionally, taking into consideration the physical, chemical, and biological consequences of size.

INDUSTRY INSIGHTS

Why More Drug Developers Are Turning To Hot Melt Extrusion

Poor API solubility delays pipelines. Discover how hot-melt extrusion creates amorphous solid dispersions to break down crystal lattices and boost bioavailability via solvent-free manufacturing.

Applying Automation To The Manufacture Of Drug Delivery Devices

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Accelerate LNP Manufacturing With Automated Process Development

Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential.

The Engineering Decisions That Shape Drug Delivery Performance

Data-driven design is critical for combination products. Learn how a structured engineering approach helps identify risks early and supports scalable, global manufacturing readiness.

Advanced Nasal Drug Delivery: From Development To Commercialization

As nasal therapies advance, integrating formulation, device, manufacturing, and regulatory planning early helps reduce risk, accelerate launch, and support patient outcomes.

SOLUTIONS

Improve The Performance Of Your Formulations

From Discovery To Impact: New Approach Methodologies